FDA Approves Efsitora Weekly Insulin for Type 2 Diabetes
2026-09-28
MedPage Today) — The FDA approved the once-weekly basal insulin efsitora (Onswik), drugmaker Eli Lilly announced on Thursday. Indicated as an adjunct to diet and exercise for adults with type 2 diabetes, the therapy delivers steady basal insulin…Read MoreContinue Reading